Partitioning the Genomic Components of Behavioral Disinhibition and Substance Use (Disorder) Using Genomic Structural Equation Modeling
View ORCID ProfileTanya B. Horwitz, View ORCID ProfileKaterina Zorina-Lichtenwalter, View ORCID ProfileDaniel E. Gustavson, View ORCID ProfileAndrew D. Grotzinger, View ORCID ProfileMichael C. Stallings
doi: https://doi.org/10.1101/2024.02.20.24303036
Tanya B. Horwitz
aInstitute for Behavioral Genetics, University of Colorado Boulder, 1480 30th St, Boulder, CO, United States of America 80303
bPsychology and Neuroscience, University of Colorado Boulder, Meunzinger D244, 345 UCB, Boulder, CO, United States of America 80303
Katerina Zorina-Lichtenwalter
aInstitute for Behavioral Genetics, University of Colorado Boulder, 1480 30th St, Boulder, CO, United States of America 80303
Daniel E. Gustavson
aInstitute for Behavioral Genetics, University of Colorado Boulder, 1480 30th St, Boulder, CO, United States of America 80303
Andrew D. Grotzinger
aInstitute for Behavioral Genetics, University of Colorado Boulder, 1480 30th St, Boulder, CO, United States of America 80303
bPsychology and Neuroscience, University of Colorado Boulder, Meunzinger D244, 345 UCB, Boulder, CO, United States of America 80303
Michael C. Stallings
aInstitute for Behavioral Genetics, University of Colorado Boulder, 1480 30th St, Boulder, CO, United States of America 80303
bPsychology and Neuroscience, University of Colorado Boulder, Meunzinger D244, 345 UCB, Boulder, CO, United States of America 80303

Data Availability Statement
Links to available (unrestricted) summary statistics are provided in Table 1.
Posted February 27, 2024.
Partitioning the Genomic Components of Behavioral Disinhibition and Substance Use (Disorder) Using Genomic Structural Equation Modeling
Tanya B. Horwitz, Katerina Zorina-Lichtenwalter, Daniel E. Gustavson, Andrew D. Grotzinger, Michael C. Stallings
medRxiv 2024.02.20.24303036; doi: https://doi.org/10.1101/2024.02.20.24303036
Partitioning the Genomic Components of Behavioral Disinhibition and Substance Use (Disorder) Using Genomic Structural Equation Modeling
Tanya B. Horwitz, Katerina Zorina-Lichtenwalter, Daniel E. Gustavson, Andrew D. Grotzinger, Michael C. Stallings
medRxiv 2024.02.20.24303036; doi: https://doi.org/10.1101/2024.02.20.24303036
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)